Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

GSK plc DRC (GSK)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow GSK plc DRC's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
39.75 +0.48    +1.22%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
39.75
0.00
0.00%
16:19:46 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,494,235
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 39.37 - 39.76
GSK plc DRC 39.75 +0.48 +1.22%

GSK Balance Sheet

 
Featured here, the Balance Sheet for GSK plc DRC, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Total Current Assets 18644 21240 19348 19719
Cash and Short Term Investments 5688 6683 6504 6975
Cash - - - -
Cash & Equivalents 2936 3177 3140 2890
Short Term Investments 450 3506 114 4085
Total Receivables, Net 6995 8874 7095 7129
Accounts Receivables - Trade, Net 5905 8544 6776 6833
Total Inventory 5498 5480 5512 5355
Prepaid Expenses 355 - - -
Other Current Assets, Total 108 203 237 260
Total Assets 59005 60862 59461 58596
Property/Plant/Equipment, Total - Net 9957 9454 9315 9414
Property/Plant/Equipment, Total - Gross 19591 - - -
Accumulated Depreciation, Total -9634 - - -
Goodwill, Net 6811 6973 6716 6857
Intangibles, Net 14768 15295 15531 14160
Long Term Investments 1219 1142 1350 1340
Note Receivable - Long Term 1081 330 319 296
Other Long Term Assets, Total 1557 1148 1402 1496
Other Assets, Total 7421 5925 7817 8181
Total Current Liabilities 21068 22390 22108 20696
Accounts Payable 3717 14692 13101 13280
Payable/Accrued - - - -
Accrued Expenses 4084 - - -
Notes Payable/Short Term Debt 893 2520 3635 2579
Current Port. of LT Debt/Capital Leases 1920 2323 2286 1682
Other Current liabilities, Total 10454 2855 3086 3155
Total Liabilities 46210 48243 47302 47284
Total Long Term Debt 15205 15999 15553 16644
Long Term Debt 14154 15999 15553 16644
Capital Lease Obligations 1051 - - -
Deferred Income Tax 311 402 500 290
Minority Interest -552 -514 -532 -508
Other Liabilities, Total 9172 7296 5888 7433
Total Equity 12795 12619 12159 11312
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1348 1348 1348 1348
Additional Paid-In Capital 3451 3450 3450 3449
Retained Earnings (Accumulated Deficit) 7743 7017 6418 5655
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 253 804 943 860
Total Liabilities & Shareholders' Equity 59005 60862 59461 58596
Total Common Shares Outstanding 4056.26 4056 4053 4052
Total Preferred Shares Outstanding - - - -
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

GSK Comments

Write your thoughts about GSK plc DRC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
William Hineser
William Hineser Feb 28, 2024 2:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Most large international pharm companies are good long term investments.
Reply
0 0
Report
William Hineser
William Hineser Feb 05, 2024 9:45AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Finally, some improvement, with reservations.
Reply
0 0
Report
William Hineser
William Hineser Nov 14, 2023 10:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
One of the few pharm companies not improving. Why?
Reply
0 0
Report
Arth Dlg
Arth Dlg Apr 27, 2023 9:32AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
RSV approval is a great announcement. I am buying :)
Reply
1 0
Report
Jeff Chui
Jeff Chui Sep 15, 2022 9:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buy here 31.2 Someone just bought 700k shares ($21million) pre market
Reply
2 0
Report
daniel daniel
daniel daniel Sep 15, 2022 9:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
yes i entered at the same price, went against my rule of waiting the SPY to fall to the support level which would be around 365, i hope it was not a trick to get some new hodlers .... yet i feel relaxed because of the high dividend
Reply
2 0
Report
peter pan
peter pan Aug 18, 2022 7:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
GSK will fall to $25 level. Mark my words.
Reply
4 8
Report
Jay Ow
Jay Ow Aug 18, 2022 7:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
They all can do whatever after covid fraud. I do not want see any of these MED stocks at all for me and for many others they are just Murderers
Reply
0 1
Report
Dan Dc
DanDc Aug 17, 2022 10:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bought @ 34.36
Reply
1 0
Report
Jaeyong Lee
Jaeyong Lee Aug 17, 2022 10:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bought @33.07
Reply
1 0
Report
Dan Dc
DanDc Aug 17, 2022 10:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i bought for long term , now the stimulus in Europe will pump this stock.
Reply
0 1
Report
Patricio Garnica
Patricio Garnica Aug 11, 2022 1:16PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
is It a good entry point?
Reply
5 0
Report
Mo Ali
Av8er31 Aug 11, 2022 1:16PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Absolutely.
Reply
1 1
Report
William Hineser
William Hineser Aug 11, 2022 10:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Glad I don't have many shares.
Reply
0 0
Report
True Thao
True Thao Aug 11, 2022 10:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
🤣🤣🤣
Reply
0 0
Report
Jonathan Sanders
Jonathan Sanders Aug 03, 2022 9:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
GSK recently struck a deal to purchase Sierra Oncology (SRRA) for a total of $1.9 billion to bolster its oncology offerings.... what we think about this acquisition
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email